Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,373 stories indexed, page 135 of 157

🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care published Report on Form 20-F for fiscal year 2025

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care places bond with a volume of 500 million Euros | Fresenius Medical Care

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care publishes its Annual Report 2025: The power of care

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Media overview

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

Health & Wellness

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.com

High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis

Fresenius Medical CareOriginal source
🇺🇸Industryfreenome.com

Walgreens and Freenome Establish Partnership to Increase Diversity in Research for the Early Detection of Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Presents a Subject Population Analysis of a Clinical Study Using a Multiomics Blood Test for the Early Detection of Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company’s Next Chapter of Commercial Growth and Product Innovation

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Initiates PROACT LUNG Clinical Study for the Early Detection of Lung Cancer Using Blood Test Developed on Multiomics Platform

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Appoints Linh H. Le as Chief Financial Officer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Announces JAMA Publication of Data from Pivotal Study of its Blood-Based Test for Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Adds University of Chicago as a Partner for its Vallania Study

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Adds Renown Health as Partner for The Sanderson Study

FreenomeOriginal source
🇺🇸Industryfreenome.com

Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd

FreenomeOriginal source
🌍Investorfrazierhealthcare.com

Pairing Fast Growing Companies with Industry Leaders

Frazier Healthcare PartnersOriginal source
🌍Investorfrazierhealthcare.com

CPS Solutions, LLC Announces Acquisition of Trellis Rx, LLC

Frazier Healthcare PartnersOriginal source
🌍Investorfrazierhealthcare.com

Frazier Healthcare Partners Acquires Apollo Intelligence

Frazier Healthcare PartnersOriginal source
🌍Investorfrazierhealthcare.com

BD Completes Acquisition of Parata Systems

Frazier Healthcare PartnersOriginal source
🌍Investorfrazierhealthcare.com

A Center of Excellence to Create Value at Our Companies

Frazier Healthcare PartnersOriginal source
🌍Investorfrazierhealthcare.com

32 Years of Building and Growing Healthcare Companies

Frazier Healthcare PartnersOriginal source
🇺🇸Researchflagshippioneering.com

UK and Singapore launch a regulatory innovation corridor to speed up…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

King Abdullah International Medical Research Center and Flagship…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering Launches Serif Biomedicines to Establish Modified…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering Appoints Eric Topol as Academic Advisor to…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome 2026

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering Announces New Agreements with ProFound…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering Announces Formation of Terion, a Company…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering and the Francis Crick Institute Announce…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering and Repertoire® Immune Medicines Announce…

Flagship PioneeringOriginal source
🇺🇸Researchflagshippioneering.com

Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug…

Flagship PioneeringOriginal source
🇺🇸Industryeyenuk.com

Multinational Optical Retailer Piloting AI and Telemedicine Technology to Protect Community Eye Health During the COVID-19 Pandemic

EyenukOriginal source
🇺🇸Industryeyenuk.com

Largest AI Study in British Diabetic Eye Screening Published with Exceptional EyeArt Results

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk Supports Federal Efforts to Promote Nationwide Adoption of Interoperable Standards for Ophthalmic Imaging Data

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk Secures World’s First National Health System Deployment of Autonomous AI Eye Screening Technology

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk Reports Strong 2021 Business Growth

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk Joins the Population Health Alliance, Paving Way for Autonomous AI to Improve Diabetes Complications

EyenukOriginal source
🇺🇸Industryeyenuk.com

New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk AI Techlology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation

EyenukOriginal source
🇺🇸Industryeyenuk.com

Eyenuk Appoints Mads Dall as Chairman of the Board and Gaurav Agarwal as Chief Executive Officer

EyenukOriginal source